Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S (QNRX)

13 filings reported holding QNRX - Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S as of Q2 2024.
Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S (QNRX) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 220K shares of 9.35M outstanding shares and own 2.35% of the company stock.
Largest 10 shareholders include Altium Capital Management LP (103K shares), RENAISSANCE TECHNOLOGIES LLC (34.2K shares), TWO SIGMA SECURITIES, LLC (23.5K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (15.4K shares), RHUMBLINE ADVISERS (14.8K shares), TWO SIGMA INVESTMENTS, LP (10.9K shares), OneDigital Investment Advisors LLC (10.4K shares), UBS Group AG (6.1K shares), BANK OF AMERICA CORP /DE/ (1K shares), and JPMORGAN CHASE & CO (645 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.